Conserved Transcriptional Regulatory Mechanisms in Aortic Valve Development and Disease

• Published in: Arteriosclerosis, thrombosis, and vascular biology Vol. 34; no. 4; pp. 737 - 741
• Main Authors: Wirrig, Elaine E, Yutzey, Katherine E
• Format: Journal Article
• Language: English
• Published: United States American Heart Association, Inc 01.04.2014
• Subjects: Animals; Aortic Valve - embryology; Aortic Valve - metabolism; Aortic Valve - pathology; Aortic Valve Stenosis - genetics; Aortic Valve Stenosis - metabolism; Aortic Valve Stenosis - pathology; Calcinosis - genetics; Calcinosis - metabolism; Calcinosis - pathology; Epithelial-Mesenchymal Transition; Gene Expression Regulation, Developmental; Heart Valve Diseases - genetics; Heart Valve Diseases - metabolism; Heart Valve Diseases - pathology; Heart Valve Diseases - therapy; Humans; Morphogenesis; Transcription Factors - genetics; Transcription Factors - metabolism; Transcription, Genetic; aortic valve stenosis; fetal heart; bicuspid aortic valve; transcription factors; extracellular matrix
• ISSN: 1079-5642; 1524-4636
• DOI: 10.1161/ATVBAHA.113.302071

There is increasing evidence for activation of developmental transcriptional regulatory pathways in heart valve disease. Here, we review molecular regulatory mechanisms involved in heart valve progenitor development, leaflet morphogenesis, and extracellular matrix organization that also are active in diseased aortic valves. These include regulators of endothelial-to-mesenchymal transitions, such as the Notch pathway effector RBPJ, and the valve progenitor markers Twist1, Msx1/2, and Sox9. Little is known of the potential reparative or pathological functions of these developmental mechanisms in adult aortic valves, but it is tempting to speculate that valve progenitor cells could contribute to repair in the context of disease. Likewise, loss of either RBPJ or Sox9 leads to aortic valve calcification in mice, supporting a potential therapeutic role in prevention of disease. During aortic valve calcification, transcriptional regulators of osteogenic development are activated in addition to valve progenitor regulatory programs. Specifically, the transcription factor Runx2 and its downstream target genes are induced in calcified valves. Runx2 and osteogenic genes also are induced with vascular calcification, but activation of valve progenitor markers and the cellular context of expression are likely to be different for valve and vascular calcification. Additional research is necessary to determine whether developmental mechanisms contribute to valve repair or whether these pathways can be harnessed for new treatments of heart valve disease.